3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
32
Metastatic Castration-resistant Prostate Cancer
3
Prostatic Diseases
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Urogenital Neoplasms
1
Thrombocytopenia
1
Prostatic Neoplasms, Castration-Resistant
1
Prostate Cancer Metastatic
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Hormone Naive Prostate Cancer
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Liver Neoplasms
1
High-Risk Localized Prostate Cancer
1
Glioma
1
Glioblastoma
1
Genital Neoplasms, Male
1
Genital Diseases, Male
1
Disease
1
Cytopenia
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Astrocytoma
1
Anemia
1
Interventions
Cisplatin
21
pembrolizumab
16
Gemcitabine
16
Paclitaxel
15
Radiotherapy
14
Carboplatin
14
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
9
Cetuximab
9
Magnetic Resonance Spectroscopy
8
Radiation
7
padeliporfin
6
Specimen Handling
6
Oxaliplatin
6
Fluorouracil
6
Drug Therapy
6
Docetaxel
6
Capecitabine
6
Bevacizumab
6
anlotinib
5
Nivolumab
5
Irinotecan
5
Erlotinib Hydrochloride
5
Celecoxib
5
poly ICLC
4
fludarabine
4
Standard of Care
4
Sorafenib
4
Leucovorin
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma
×
Pluvicto
×
Clear all
NCT07587814
2026-05-14
COCORIVO
Centre Henri Becquerel
Phase NA
Not yet recruiting
100 enrolled